Faculty and Staff

Dr. Evins completed her residency in adult psychiatry at the Massachusetts Mental Health Center and Longwood Psychiatry Residency Training Program. In addition, she completed a fellowship in molecular biology at the Mailman Research Center of McLean Hospital, a fellowship in clinical research at the Massachusetts General Hospital, and a Masters in Public Health with a concentration in Clinical Effectiveness at the Harvard School of Public Health in 2005. She has been an active member of the MGH Schizophrenia and Depression Clinical and Research Program since 1995. Dr. Evins' research interests include pharmacotherapy for nicotine dependence, co-occurring psychiatric and substance use disorders, negative symptoms and cognitive dysfunction in schizophrenia.

Additionally, she is studying the effects of various medications on reward responsiveness and other potential biomarkers of vulnerability to addiction and of treatment response. Dr Evins has authored articles, book chapters, and reviews concerning topics in this field. Her articles are published in scientific journals, such as American Journal of Psychiatry, Neuropsychopharmacology, Biological Psychiatry, Journal of Clinical Psychopharmacology, and Journal of Neural Transmission. Dr. Evins has twice been the recipient of the National Alliance for Research on Schizophrenia and Affective Disorders Young Investigator Award, and has been awarded the New Clinical Drug Evaluation Unit Award for Young Investigators sponsored by the National Institute of Mental Health, the Massachusetts Department of Public Health Young Investigator Award and two career development awards from NIDA. She is currently supported by six major grants from NIDA to test novel therapies for nicotine dependence in the general population and in those with co-occurring psychiatric disorders.

Email: a_eden_evins@hms.harvard.edu

Dr. Kelly is the Elizabeth R. Spallin Associate Professor of Psychiatry in Addiction Medicine at Harvard Medical School, the founder and Director of the Recovery Research Institute at MGH. The American Psychological Association (APA) Society of Addiction Psychology, and is also a Fellow of APA. He has served as a consultant to U.S. federal agencies such as the White House Office of National Drug Control Policy (ONDCP), the Substance Abuse and Mental Health Services Administration (SAMHSA), and the national Institutes of Health (NIH); to non-Federal institutions, such as the Betty Ford Institute and the Hazelden Foundation; and internationally to foreign governments. He is currently an Associate Editor for the journals, Addiction, and the Journal of Substance Abuse Treatment. He has published more than 100 peer-reviewed articles, reviews, and chapters in the field of addiction. His clinical and research work has focused on addiction treatment and the recovery process which has included specific research on the effectiveness of mutual-help groups, such as Alcoholics Anonymous, as adjuncts to formal care. His additional research endeavors have focused on the translation and implementation of evidence-based practice, addiction and criminal justice, addiction treatment theories and mechanisms of action, and reducing stigma associated with addiction.

Dr. John F. Kelly, PHD has been recognized as one of the top Boston Psychology practices.
Verified by
Opencare.com

Email: jkelly11@mgh.harvard.edu

Dr. Corinne Cather earned her undergraduate degree in biopsychology at Hamilton College in Clinton, NY and her doctorate in clinical psychology from Rutgers University where she received specialized training in cognitive behavioral therapy (CBT) and behavioral medicine. She completed an internship at the University of Medicine and Dentistry of New Jersey (formerly Rutgers) and joined the Schizophrenia Clinical and Research Program in 1999 as a fellow. She has extensive experience as a clinician-researcher with first episode/early psychosis as well as with chronic schizophrenia and she has developed an international reputation as one of the few practitioners in the US skilled in cognitive behavioral therapy in schizophrenia. She has participated in a number of trials that investigate the efficacy of combined behavioral and psychopharmacological treatments for nicotine dependence in smokers with severe mental illness and has manualized treatments for enhancing motivation to quit smoking, smoking cessation and relapse prevention for this population of smokers.

Email: ccather@mgh.harvard.edu

Dr. Pedrelli is a clinical psychologist with expertise in comorbid disorders. She received her Ph.D in Clinical Psychology from the Joint Doctoral Program at University of California San Diego and San Diego State University and completed her post-doctoral work at MGH. Her program of research focuses on explicating the etiology of co-occurring Mood Disorders and Alcohol Use Disorders and on developing psychosocial treatments for these conditions. She has been awarded funding from Harvard Medical School, the National Institute Of Alcohol Abuse and Alcoholism, and the ABMRF/The Foundation for Alcohol Research. Her current work includes a study examining the effectiveness of a novel psychosocial intervention for heavy drinking and depressive symptoms in college students, and a multi-method study investigating positive and negative reinforcement processes at the bases of binge drinking. She has published and presented extensively on the co-occurrence of depressive symptoms and substances use among college students. She is an expert in the delivery of CBT and developed several CBT based treatment manuals for patients with co-occurring disorders.

Email: ppedrelli@mgh.harvard.edu

Dr Hoeppner is a health psychologist with expertise in fine-grained longitudinal methodology, which she uses to explicate the mechanisms underlying behavioral change. During her graduate training (Univ. of RI, MA in psychology in 2003, MS in statistics in 2005, Ph.D. in psychology in 2007), Dr Hoeppner collaborated on numerous health behavior change projects, which used computer-delivered expert systems based on the Transtheoretical Model to provide participants with tailored intervention materials. Thereafter, she completed a postdoctoral fellowship at the Center of Alcohol and Addiction Studies at Brown University that focused on addictive behaviors, particularly alcohol and tobacco use in adolescents and young adults. Dr Hoeppner joined the Center for Addiction Medicine in 2010. Her K01 research project uses Ecological Momentary Assessment (EMA) to delineate the temporal ordering of changes in smoking outcome expectancies relative to smoking cessation by collecting fine-grained, real-time data on college student smokers undergoing smoking cessation treatment. As such, her 5-year K01 training and research plan builds upon her existing strengths of advanced statistical training and experience with theory-driven health behavior interventions to enable her to take full advantage of modern technology to delineate the causal mechanisms underlying the process of smoking cessation.

Email: Email: bhoeppner@mgh.harvard.edu

Dr. Pachas received her medical degree from the San Martin de Porres University and health services management and public health training from the National University Mayor de San Marcos in Lima, Peru. Her research interests are the development of behavioral treatments and new evidence-based novel treatment for smoking cessation and relapse prevention in people with and without serious mental illness. Dr. Pachas is the recipient of the NIMH-NCDEU Young Investigator Award, the MGH Clinical Research Day Departmental Award in Psychiatry, the NIH-NIDA Interdisciplinary Research Training Institute on Hispanic Drug Abuse Fellowship, the American Society of Clinical Psychopharmacology Fellowship and the Society for Research on Nicotine and Tobacco Health Disparities fellowship. Dr Pachas is involved in the clinical component of complex Phase II trials of novel pharmacologic agents all of them for smoking cessation and relapse prevention.

Email: gpachas1@mgh.harvard.edu

Dr. Gilman received her BS from Tufts University in 2004, and her PhD in Neuroscience from Brown University in 2008, where she used neuroimaging techniques to study the acute and long-term functional and structural effects of alcohol on brain regions involved in motivation and emotion. She came to CAM in January 2013 to study the effects of cannabis on the brains of young adult users. She is the receipient of the Norman Zinberg Fellowship in Addiction Psychiatry from Harvard Medical School, as well as a Career Development Award from the National Institute on Drug Abuse entitled “Neurobehavioral Characterization of Social Influence in Drug Addiction.” Dr. Gilman’s work has been features in media outlets throughout the wrold, including Reuter’s, NPR’s Science Friday broadcast, and the BBC. More information on her work can be found at http://scholar.harvard.edu/jodigilman/news.

Email: jgilman1@mgh.harvard.edu

Dr Maravic received her BA from the University of Minnesota, Twin Cities and her MPH with a concentration in epidemiology and biostatistics from Boston University School of Public Health. She joined CAM as a research fellow in 2005 where she focused on identifying predictors of smoking cessation among those with schizophrenia. She received her PhD in Medical Anthropology and Social Science Research Methods from the University Professors Program at Boston University. Her research interests are understanding and improving the health and mental health of vulnerable populations, with a specific focus on addiction, trauma and psychotic disorders. After spending several years as director of research and evaluation at a Latino community health center and as director of analytics and behavioral science at a health engagement management company, she has returned to CAM as Project Director of the PCORI project “Integrated Smoking Cessation Treatment for Smokers with Serious Mental Illness.”

Email: mmaravic@partners.org

Dr. Bergman is a research scientist in the Recovery Research Institute (RRI) within CAM, and a licensed staff psychologist in the hospital's Addiction Recovery Management Service (ARMS), where he treats adolescents and young adults with substance use disorders (SUD). He also serves nationally as the secretary for Division 50 of the American Psychological Association (Addiction Psychology). Dr. Bergman’s research interests include treatment/recovery among young adults with co-occurring SUD and psychiatric disorders as well as community-based mutual-help organizations. His work has been recognized by the National Institute on Drug Abuse (NIDA), the Research Society on Alcoholism (RSA), and by an MGH/HMS institutional award. Dr. Bergman received his Ph.D. in clinical psychology from Nova Southeastern University in Fort Lauderdale, FL, including a predoctoral clinical internship in the MGH/HMS Department of Psychiatry. He completed a combined clinical/research postdoctoral fellowship at ARMS and CAM in 2014.

Email: bgbergman@mgh.harvard.edu

Dr. Kristina Cieslak graduated from NYU School of Medicine in 2015, and is a current resident in the MGH/McLean Adult Psychiatry Residency Program. Her research interests center on improving quality of life and health outcomes for individuals with serious mental illness in the community setting. In conjunction with the MGH Schizophrenia Program, Freedom Trail Clinic, MGH Department of Medicine and Diabetes Center, she is conducting a study of and co-leading an educational and behavioral group intervention for individuals with schizophrenia and diabetes. Other projects include providing academic detailing to primary care physicians as a part of the PCORI project “Integrated Smoking Cessation Treatment for Smokers with Serious Mental Illness” and working to improve engagement of psychiatric patients in smoking cessation treatment in the inpatient setting.

Email: kcieslak@mgh.harvard.edu

Dr. Aurora Quaye is a clinical investigator at the Center of Addiction Medicine and an Instructor in Anesthesia at Massachusetts General Hospital. Dr. Quaye received her BA in Neuroscience and Behavior from Wesleyan University and her MD from Harvard Medical School.  Dr. Quaye completed her residency in Anesthesia, Critical Care and Pain Medicine at Massachusetts General Hospital and her fellowship in Regional Anesthesia and Acute Pain Medicine at Brigham and Women’s Hospital. She serves as a member of the Acute Pain Service and the Opioid Task Force at Massachusetts General Hospital. Dr. Quaye is currently conducting research on identifying perioperative opioid reduction strategies for patients at risk of, or suffering from, opioid use disorders.

Email: aquaye@partners.org

Haiyue Zhang received her Baccalaureate summa cum laude in science with a concentration in bioinformatics at Stony Brook University in 2014 and completed her Master’s Biostatistics program at Harvard T.H. Chan School of Public Health in 2015, with the thesis “Variable Selection Under Multiple Imputation For Missing Data.” Her expertise includes data managing, statistical modeling, survival analysis, and longitudinal analysis. With a background in biology and applied mathematics, she has research experience in the regulation of gene expression during Drosophila early development.

Email: haz520@mail.harvard.edu

Dr. Schuster received her BA from University of Maryland, College Park and her PhD in Clinical Psychology from University of Illinois at Chicago in 2014. In graduate school, she was funded by a NIDA National Research Service Award to study the cognitive effects of cannabis and tobacco use among at-risk young adults using ecological momentary assessment. She joined CAM in July 2014 as a post-doctoral fellow after completing her clinical internship in neuropsychology at MGH/Harvard Medical School. She is the recipient of the Norman Zinberg Fellowship in Addiction Psychiatry and the Livingston Fellowship from Harvard Medical School as well as the Louis V. Gerstner III Research Scholar Award from MGH. She is currently conducting research based out of Boston-area high schools on the utility of contingency management interventions in promoting cannabis abstinence as well as the reversibility of cognitive deficits during 30 days of cannabis discontinuation.

Email: rschuster@mgh.harvard.edu

Hasan Onur Keles is a Research Fellow at Harvard Medical School/Massachusetts General Hospital with the Center for Addiction Medicine. He received his PhD in Biomedical Engineering from University of Houston in 2015. Dr. Keles has obtained training in a number of disciplines including neuroimaging, electrophysiology, and nano- and micro-scale technologies. During his stay at Harvard Medical School and University of Houston, he had the opportunity to apply his background in engineering to biology and medicine. Dr. Keles has contributed more than 30 scientific publications and conference papers. Currently, Dr. Keles focuses on the neuroimaging techniques to understand the acute and long-term effects of addiction (cannabis) on the brain.

Email: hkeles@partners.org

Dr. Vilsaint is a community psychologist who received her BA from the University of North Carolina at Chapel Hill and her Ph.D. in psychology from the University of Virginia. In graduate school, she was funded by a National Research Service Award (F31) from the National Institute on Drug Abuse (NIDA) to study racial/ethnic disparities as outcomes of drug use. She also uses Item Response Theory to evaluate tests and measurements.

Email: cvilsaint@mgh.harvard.edu

Dr. David Eddie received his B.A. from Columbia University and Ph.D. in clinical psychology from Rutgers University. He completed his clinical internship at Massachusetts General Hospital, Harvard Medical School. While at Rutgers, he investigated neurobiological vulnerabilities that heighten risk for the development of dependence on alcohol and other drugs, as well as processes that maintain addictive disorders. He continues this research at Massachusetts General Hospital’s Center for Addiction Medicine and Recovery Research Institute, where he is presently investigating psychophysiological biomarkers of alcohol use disorder relapse risk. He is also interested in addiction treatment and recovery processes, as well as drug and treatment policy, and is membership, and conference program chair for the American Psychological Association’s Society of Addiction Psychology.

Email: deddie@mgh.harvard.edu

Julie Cristello graduated from Saint Anselm College in 2012, where she majored in psychology.  She currently works on three studies funded by the National Institute of Health designed to examine addiction treatment and mechanisms of behavior change.  Her research interests include early intervention and substance use treatment for at-risk youth.

Email: jcristello@mgh.harvard.edu

Jessica Powers graduated with her BA in Psychology and Sociology from Northwestern University in 2015. While at CAM, she has been a Clinical Research Coordinator on two NIH funded clinical studies investigating treatments for nicotine dependence. Her current project is a Patient-Centered Outcomes Research Institute (PCORI) funded study investigating integrated smoking cessation treatment for smokers with serious mental illness. Her research interests include the commorbidity of addiction and mental illness, along with role of affect and cognition in substance use.

Email: jpowers17@mgh.harvard.edu

Milena Radoman, born and raised in Montenegro, graduated from Wellesley College in 2015, where she majored in Neuroscience. At CAM she is working primarily with Dr. Gilman on acquisition of neurocognitive data, fMRI and fNIRS analysis. Additionally, she designs and programs computer tasks needed for the studies and helps run analytical software used in the Center. Her research interests include understanding neuroscience underlying nicotine addiction as well as decision-making and social influence in people who smoke marijuana and suffer from major depressive disorder. She is a language enthusiast and enjoys wilderness activities.

Email: mradoman@mgh.harvard.edu

Nour Azzouz graduated from Wellesley College in 2015, where she majored in Neuroscience. Currently, she is involved in three NIH funded clinical studies including the Nicotine Reduction in Cigarette Smokers trial, the Decision-Making and Drug Use trial and the Neural mechanisms of Food-Related Emotion Regulation trial. Her general areas of study include adolescent psychiatry, developmental neuroscience, and the neural correlates of decision making, emotion regulation, and addiction. She is primarily interested in investigating the neurobiological effects of childhood trauma on brain development.

Email: nazzouz@mgh.harvard.edu

Nilo Fallah-Sohy graduated from the University of Maryland in 2013, where she majored in psychology.  She currently coordinates a study which aims to characterize and evaluate Recovery Commuinity Centers in New England and New York.  Her research interests include screening and prevention in schools, as well as substance use and co-occuring disorders.

Email: nfallah-sohy@mgh.harvard.ed

Nate Kelly graduated from the University of Massachusetts Boston in 2015 where he pursued a double major of psychology and sociology. He currently works as a coordinator for two studies, as well as the Recovery Research Institute. Apart from substance use treatment, Nate’s other research interests are communication and forensic psychology.

Madeleine Fontaine graduated with her BA in Psychology from Clark University in 2015. At CAM she is working primarily on the Patient-Centered Outcomes Research Institute (PCORI) funded study investigating integrated smoking cessation treatment for smokers with serious mental illness. Her research interests include the intersection of race, class, and gender on addiction and substance use.

Email: mfontaine2@mgh.harvard.edu

Alexandra Plante is the Marketing Communications Coordinator of the Recovery Research Institute. She manages written and visual content across social media accounts, the recoveryanswers.org website, the Recovery Research Review monthly newsletter, and coordinates all media inquiries to the institute. Alexandra received her B.A in Communication at the University of Massachusetts, Amherst and her M.A in Quantitative Research in Communication from the University at Buffalo. In addition to substance use treatment and recovery, her research interests include studies of human behavior and decision-making.

Email: aplante1@mgh.harvard.edu

Eve Manghis graduated with her BA in Social Studies from Harvard College in 2016. At CAM she works on the PCORI-funded study investigating integrated smoking cessation treatment for smokers with serious mental illness. She also works on Dr. Jodi Gilman’s fNIRS study examining the impacts of marijuana on the brain. Her research interests include the neurological effects of substance use on cognition and mental illness and the role of social and economic factors in determining mental health outcomes.

Email: emanghis@mgh.harvard.edu

Mike obtained his BS in Biology from the University of Massachusetts in Boston. He is involved in the Patient-Centered Outcomes Research Institute (PCORI) project at the Center for Addiction Medicine aiming to integrate smoking cessation medicines to people with serious mental illness. Mike’s main interest in translational addiction research and global dissemination of new medical discoveries.  

Email: mvilme@mgh.harvard.edu

Christopher McGovern graduated from Stonehill College with a BA in Psychology. His current role at CAM involves working as a research coordinator on a study investigating integrated smoking cessation treatment for smokers with serious mental illness, which is funded by the Patient-Centered Outcomes Research Institute. He is primarily interested in the correlates between substance abuse, serious mental illness, and suicide.

Email: cmcgovern3@mgh.harvard.edu